FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DST1

Real-time Bid/Ask 09:06:51 2024-06-17 am EDT
3.82 EUR / 4.82 EUR +16.13% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-86.15%
1 month-54.52%
Date Price Change
24-06-17 3.85 +3.49%
24-06-14 3.72 -41.69%
24-06-13 6.38 -6.59%
24-06-12 6.83 -10.84%
24-06-11 7.66 -6.93%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 05:29 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DST
ISINDE000JK5DST1
Date issued 2024-03-22
Strike 40.33 $
Maturity Unlimited
Parity 1.4 : 1
Emission price 10.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 26.86
Lowest since issue 1.29
Spread 1
Spread %20.75%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
45.33 USD
Average target price
49.93 USD
Spread / Average Target
+10.16%
Consensus